Abstract
The primary aims of this randomized controlled trial are to evaluate the short-term efficacy of duloxetine on pain intensity reduction in patients with chronic temporomandibular disorders (TMD) and to investigate the predictive value of the inhibitory pain modulation phenotype on this response. Eighty patients with chronic TMD will be randomized and concealed allocated into two treatment …